Your browser doesn't support javascript.
loading
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants.
Goldblatt, David; Andrews, Nick J; Sheppard, Carmen L; Rose, Samuel; Aley, Parvinder K; Roalfe, Lucy; Southern, Jo; Robinson, Hannah; Pearce, Emma; Plested, Emma; Johnson, Marina; Litt, David J; Fry, Norman K; Waight, Pauline; Snape, Matthew D; Miller, Elizabeth.
Afiliación
  • Goldblatt D; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom. Electronic address: d.goldblatt@ucl.ac.uk.
  • Andrews NJ; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, United Kingdom.
  • Sheppard CL; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London Vaccine Preventable Bacteria Section, National Infection Service Public Health England Colindale, United Kingdom.
  • Rose S; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London Vaccine Preventable Bacteria Section, National Infection Service Public Health England Colindale, United Kingdom.
  • Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Roalfe L; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom.
  • Southern J; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, United Kingdom.
  • Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Pearce E; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom.
  • Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Johnson M; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom.
  • Litt DJ; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, London Vaccine Preventable Bacteria Section, National Infection Service Public Health England Colindale, United Kingdom.
  • Fry NK; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, United Kingdom.
  • Waight P; Infection, Immunity and Inflammation Department, UCL Great Ormond Street Institute of Child Health Biomedical Research Centre, London, United Kingdom.
  • Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom and NIHR Oxford Biomedical Research Centre, United Kingdom.
  • Miller E; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom.
Vaccine ; 41(19): 3019-3023, 2023 05 05.
Article en En | MEDLINE | ID: mdl-37045683
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Child / Humans / Infant País/Región como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Child / Humans / Infant País/Región como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article